Skip to main navigation Skip to search Skip to main content

Purinergic receptor expression and cellular responses to purinergic agonists in human prostate cancer cells

  • Kornkamon Lertsuwan
  • , Wachen Peters
  • , Lindsay Johnson
  • , Jomnarong Lertsuwan
  • , Irene Marwa
  • , Robert A. Sikes
  • Mahidol University
  • University of Delaware
  • Laboratory of Chemical Carcinogenesis

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Abstract

Background: Anticancer activity of extracellular nucleotides has been investigated in many types of cancer. Herein, the effects of extracellular nucleotides and the receptor profile for these nucleotides on prostate cancer (PCa) were elaborated. Materials and Methods: PCa cell lines representing different stages of PCa were used. The effects of ATP and adenosine on PCa growth and migration on different extracellular matrix proteins were examined by MTT and wound-healing assays. Purinergic receptor profiling was carried out by reverse transcription-polymerase chain reaction (RT-PCR). Results: A growth-inhibitory effect of ATP and adenosine was observed on all PCa cell lines tested. Several ATP-recognized P2 receptors and adenosine receptors were commonly expressed in PCa cell lines. Neither ATP nor adenosine had any significant effect on PCa migration. Conclusion: ATP and adenosine had an antiproliferative effect on PCa cells without affecting their motility, indicating their potential as a novel therapy for PCa.

Original languageEnglish
Pages (from-to)529-538
Number of pages10
JournalAnticancer Research
Volume37
Issue number2
DOIs
Publication statusPublished - 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ATP
  • Adenosine
  • Growth inhibition
  • Prostate cancer

Fingerprint

Dive into the research topics of 'Purinergic receptor expression and cellular responses to purinergic agonists in human prostate cancer cells'. Together they form a unique fingerprint.

Cite this